Cite
MLA Citation
Christopher T Ritchlin et al.. “Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial.” Lancet, vol. 395, no. 10222, 2019, pp. 427–440. http://access.bl.uk/ark:/81055/vdc_100099963680.0x000047